Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial
Marc Mooney, David V. Herin, Joy M. Schmitz, et al.
Drug and Alcohol Dependence (2008) Vol. 101, Iss. 1-2, pp. 34-41
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

The effectiveness of compulsory drug treatment: A systematic review
Dan Werb, Adeeba Kamarulzaman, Meredith C. Meacham, et al.
International Journal of Drug Policy (2015) Vol. 28, pp. 1-9
Open Access | Times Cited: 201
The treatment of cocaine use disorder
Kyle M. Kampman
Science Advances (2019) Vol. 5, Iss. 10
Open Access | Times Cited: 192
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
Christopher L. German, Michelle Baladi, Lisa M. McFadden, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1005-1024
Open Access | Times Cited: 164
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder
Frances R. Levin, John J. Mariani, Sheila Specker, et al.
JAMA Psychiatry (2015) Vol. 72, Iss. 6, pp. 593-593
Open Access | Times Cited: 153
Methamphetamine‐Associated Cardiomyopathy
Sekon Won, Robert Hong, Ralph V. Shohet, et al.
Clinical Cardiology (2013) Vol. 36, Iss. 12, pp. 737-742
Open Access | Times Cited: 132
Efficacy of Psychostimulant Drugs for Cocaine Dependence
Xavier Castells, Miguel Casas, Clara Pérez‐Mañá, et al.
Cochrane database of systematic reviews (2010)
Closed Access | Times Cited: 125
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter
Maarten E. A. Reith, Bruce E. Blough, Weimin Hong, et al.
Drug and Alcohol Dependence (2014) Vol. 147, pp. 1-19
Open Access | Times Cited: 125
Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research
Paul W. Czoty, William W. Stoops, Craig R. Rush
Pharmacological Reviews (2016) Vol. 68, Iss. 3, pp. 533-562
Open Access | Times Cited: 125
Incubation of Methamphetamine and Palatable Food Craving after Punishment-Induced Abstinence
Irina N. Krasnova, Nathan J. Marchant, Bruce Ladenheim, et al.
Neuropsychopharmacology (2014) Vol. 39, Iss. 8, pp. 2008-2016
Open Access | Times Cited: 124
Novel pharmacotherapeutic treatments for cocaine addiction
Daryl Shorter, Thomas R. Kosten
BMC Medicine (2011) Vol. 9, Iss. 1
Open Access | Times Cited: 113
Evidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
Wimk van den Brink
Current Drug Abuse Reviews (2012) Vol. 5, Iss. 1, pp. 3-31
Closed Access | Times Cited: 112
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
Vítor S. Tardelli, Adam Bisaga, Felipe B. Arcadepani, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2233-2255
Closed Access | Times Cited: 111
Comparison of Treatments for Cocaine Use Disorder Among Adults
Brandon S. Bentzley, Summer S. Han, Sophie Neuner, et al.
JAMA Network Open (2021) Vol. 4, Iss. 5, pp. e218049-e218049
Open Access | Times Cited: 96
Psychostimulant drugs for cocaine dependence
Xavier Castells, Ruth Cunill, Clara Pérez‐Mañá, et al.
Cochrane library (2016) Vol. 2016, Iss. 9
Open Access | Times Cited: 95
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

Journal of Addiction Medicine (2024) Vol. 18, Iss. 1S, pp. 1-56
Closed Access | Times Cited: 13
In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat
Michael H. Baumann, Robert D. Clark, William L. Woolverton, et al.
Journal of Pharmacology and Experimental Therapeutics (2011) Vol. 337, Iss. 1, pp. 218-225
Open Access | Times Cited: 107
Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies
David V. Herin, Craig R. Rush, John Grabowski
Annals of the New York Academy of Sciences (2010) Vol. 1187, Iss. 1, pp. 76-100
Closed Access | Times Cited: 102
A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction
G Galloway, Raymond Buscemi, Jeremy Coyle, et al.
Clinical Pharmacology & Therapeutics (2010) Vol. 89, Iss. 2, pp. 276-282
Open Access | Times Cited: 99
Cognitive enhancers in the treatment of substance use disorders: Clinical evidence
Kathleen T. Brady, Kevin M. Gray, Bryan K. Tolliver
Pharmacology Biochemistry and Behavior (2011) Vol. 99, Iss. 2, pp. 285-294
Open Access | Times Cited: 84
Extended-Release Mixed Amphetamine Salts and Topiramate for Cocaine Dependence: A Randomized Controlled Trial
John J. Mariani, Martina Pavlicová, Adam Bisaga, et al.
Biological Psychiatry (2012) Vol. 72, Iss. 11, pp. 950-956
Open Access | Times Cited: 79
Psychostimulant Treatment of Cocaine Dependence
John J. Mariani, Frances R. Levin
Psychiatric Clinics of North America (2012) Vol. 35, Iss. 2, pp. 425-439
Open Access | Times Cited: 77
Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies
Benedikt Fischer, Peter Blanken, Dartiu Xavier da Silveira, et al.
International Journal of Drug Policy (2015) Vol. 26, Iss. 4, pp. 352-363
Closed Access | Times Cited: 75
Psychostimulant addiction treatment
Karran A. Phillips, David H. Epstein, Kenzie L. Preston
Neuropharmacology (2014) Vol. 87, pp. 150-160
Open Access | Times Cited: 73
Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder
Margaret C. Wardle, Jessica Vincent, Robert Suchting, et al.
Journal of Substance Abuse Treatment (2016) Vol. 72, pp. 32-39
Open Access | Times Cited: 72
Agonist Medications for the Treatment of Cocaine Use Disorder
S. Stevens Negus, Jack E. Henningfield
Neuropsychopharmacology (2014) Vol. 40, Iss. 8, pp. 1815-1825
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top